Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
- Losartan Potassium Structural Formula - hisun losartan 01
- Figure 1: Kaplan-Meier estimates of the primary endpoint of time to cardiovascular death, nonfatal stroke, or nonfatal myocardial infarction in the groups treated with losartan potassium and atenolol. - hisun losartan 02
- Figure 2: Kaplan-Meier estimates of the time to fatal/nonfatal stroke in the groups treated with losartan potassium and atenolol. The Risk Reduction is adjusted for baseline Framingham risk score and - hisun losartan 03
- Figure 3: Primary Endpoint Events within Demographic Subgroups - hisun losartan 04
- Figure 4: Kaplan-Meier curve for the primary composite endpoint of doubling of serum creatinine, end stage renal disease (need for dialysis or transplantation) or death. - hisun losartan 05
- Losartan potassium tablets USP, 25 mg 90 Count - hisun losartan 06
- Losartan potassium tablets USP, 50 mg 30 Count - hisun losartan 07
- Losartan potassium tablets USP, 100 mg 30 Count - hisun losartan 08
Product Label Images
The following 8 images provide visual information about the product associated with Losartan Potassium NDC 42658-102 by Hisun Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Losartan Potassium Structural Formula - hisun losartan 01
Figure 1: Kaplan-Meier estimates of the primary endpoint of time to cardiovascular death, nonfatal stroke, or nonfatal myocardial infarction in the groups treated with losartan potassium and atenolol. - hisun losartan 02
This text provides information on the comparison of two treatments, Atenolol and Losartan Potassium, in terms of the percentage of patients reaching the primary endpoint. The adjusted risk reduction is reported as 13% with a p-value of 0.021. The study duration is indicated in months from 0 to 66.*
Figure 2: Kaplan-Meier estimates of the time to fatal/nonfatal stroke in the groups treated with losartan potassium and atenolol. The Risk Reduction is adjusted for baseline Framingham risk score and - hisun losartan 03
This text provides information about a study comparing Losartan Potassium and Atenolol in patients with stroke. The study shows an adjusted risk reduction of 25% with a p-value of 0.001. The text also mentions that 9% of patients had either a fatal or non-fatal stroke. The study was conducted over a period of 66 months.*
Figure 3: Primary Endpoint Events within Demographic Subgroups - hisun losartan 04
Figure 4: Kaplan-Meier curve for the primary composite endpoint of doubling of serum creatinine, end stage renal disease (need for dialysis or transplantation) or death. - hisun losartan 05
This text provides information on the percentage of patients who experienced an event, the risk reduction with Losartan Potassium compared to placebo, and the duration of the study in months.*
Losartan potassium tablets USP, 25 mg 90 Count - hisun losartan 06
This is a description of Losartan Potassium Tablets, USP. Each tablet contains 25 mg of Losartan Potassium. The usual adult dosage information is provided in the accompanying circular. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The container should be kept tightly closed and protected from light. The product is distributed by Hisun Pharmaceuticals USA, Inc. and manufactured in China.*
Losartan potassium tablets USP, 50 mg 30 Count - hisun losartan 07
This is information about Losartan Potassium tablets containing 50mg per tablet. The usual adult dosage should be checked in the accompanying circular. The tablets should be stored at a temperature between 20°C to 25°C. They can also be stored between 15°C to 30°C temporarily. The container should be tightly closed and protected from light. Distributed by Hisun Pharmaceuticals USA, Inc. and manufactured in China in October 2018.*
Losartan potassium tablets USP, 100 mg 30 Count - hisun losartan 08
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
